Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) | Zendy

John J.V. McMurray | Zendy; John Kjekshus | Zendy; Lars Gullestad | Zendy; Peter Dunselman | Zendy; Åke Hjalmarson | Zendy; Hans Wedel | Zendy; Magnus Lindberg | Zendy; Finn Waagstein | Zendy; Peer Grande | Zendy; J Hradec | Zendy; Gabriel Kamenský | Zendy; J Korewicki | Zendy; Timo Kuusi | Zendy; François Mach | Zendy; Naresh Ranjith | Zendy; John Wikstrand | Zendy

Open Access

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Author(s) -

John J.V. McMurray,

John Kjekshus,

Lars Gullestad,

Peter Dunselman,

Åke Hjalmarson,

Hans Wedel,

Magnus Lindberg,

Finn Waagstein,

Peer Grande,

J Hradec,

Gabriel Kamenský,

J Korewicki,

Timo Kuusi,

François Mach,

Naresh Ranjith,

John Wikstrand

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.849117

Subject(s) - rosuvastatin , medicine , placebo , rosuvastatin calcium , c reactive protein , hazard ratio , myocardial infarction , heart failure , statin , gastroenterology , clinical endpoint , confidence interval , cardiology , randomized controlled trial , inflammation , pathology , alternative medicine

We examined whether the antiinflammatory action of statins may be of benefit in heart failure, a state characterized by inflammation in which low cholesterol is associated with worse outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research